Act Wealth Management
HUMA icon

Act Wealth Management’s Humacyte HUMA Stock Holding History

Act Wealth Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.89K Hold
11,379
– – ﹤0.01% 64
2026
Q2 		$8.88K Hold
11,379
– – ﹤0.01% 64
2026
Q1 		$6.9K Hold
11,379
– – ﹤0.01% 62
2025
Q4 		$10.9K Hold
11,379
– – ﹤0.01% 61
2025
Q3 		$19.8K Hold
11,379
– – 0.01% 56
2025
Q2 		$23.8K Hold
11,379
– – 0.01% 53
2025
Q1 		$19.4K Hold
11,379
– – 0.01% 50
2024
Q4 		$57.5K Buy
+11,379
New +$56.3K 0.03% 42

Other funds holding HUMA

Wealth Effects
Wealth Effects Boston, Massachusetts $370M AUM 63.53% 1-Year Est. Return
Miramontes Capital
Miramontes Capital Newport, California $331M AUM 19.33% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Clarus Wealth Advisors
Clarus Wealth Advisors Peoria, Arizona $275M AUM 18.32% 1-Year Est. Return
Lazari Capital Management
Lazari Capital Management Woodland Hills, California $339M AUM 25.58% 1-Year Est. Return
Columbia Advisory Partners
Columbia Advisory Partners Spokane, Washington $181M AUM 18.7% 1-Year Est. Return
Hamilton Lane Advisors
Hamilton Lane Advisors Conshohocken, Pennsylvania $179M AUM 25.1% 1-Year Est. Return
Trilogy Capital
Trilogy Capital Irvine, California $2.61B AUM 14.55% 1-Year Est. Return
Onyx Bridge Wealth Group
Onyx Bridge Wealth Group Tarrytown, New York $1.14B AUM 18.43% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.14% 1-Year Est. Return

Act Wealth Management's HUMA Position: Q3 2026 in Review

Act Wealth Management held its Humacyte (HUMA) position steady in Q3 2026 at 11,379 shares worth $5.89K. The position accounts for ﹤0.01% of the portfolio, ranked #64.

Act Wealth Management first reported a position in HUMA in Q4 2024 and has held it in 8 quarters since. The position peaked at $57.5K in Q4 2024. 24 funds tracked by Wall St. Rank hold HUMA as of Q3 2026.

  • Act Wealth Management held 11,379 shares of Humacyte worth $5.89K as of Q3 2026.
  • Act Wealth Management left its Humacyte share count unchanged in Q3 2026.
  • Humacyte made up ﹤0.01% of Act Wealth Management's portfolio in Q3 2026, its #64 holding.
  • Act Wealth Management first reported a position in Humacyte in Q4 2024 and has held it in 8 quarters since.
  • Act Wealth Management's Humacyte position peaked at $57.5K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held Humacyte as of Q3 2026.

Based on Act Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.